Alan Leeb
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
-
- Vaccine Coverage and Hesitancy
Papers in
- Toxicology 18
- Pharmacovigilance and Adverse Drug Reactions 18
-
- Influenza Virus Research Studies 3
- Herpesvirus Infections and Treatments 3
- Cervical Cancer and HPV Research 1
- Co-authors
- Kristine K. Macartney (9 shared papers)Patrick M. Cashman (8 shared papers)Alexis Pillsbury (6 shared papers)Helen Quinn (4 shared papers)Annette K. Regan (2 shared papers)Tom Snelling (8 shared papers)Catherine Glover (7 shared papers)Christopher C. Blyth (5 shared papers)
- Journals
- Vaccine (6 papers)BMJ Open (4 papers)The Medical Journal of Australia (3 papers)Human Vaccines & Immunotherapeutics (2 papers)The Lancet Regional Health - Western Pacific (2 papers)
- Partner nations
- AustraliaUnited KingdomQatar
In The Last Decade
Alan Leeb
27 papers receiving 351 citations
Peers
Comparison fields: 5 of 34
- Toxicology 179
- Health 37
- Epidemiology 97
- Immunology and Allergy 14
- Infectious Diseases 50
Countries citing papers authored by Alan Leeb
This map shows the geographic impact of Alan Leeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Leeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Leeb more than expected).
Fields of papers citing papers by Alan Leeb
This network shows the impact of papers produced by Alan Leeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Leeb. The network helps show where Alan Leeb may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Leeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 49 | |
| 2 | 2018 | 39 | |
| 3 | 2015 | 32 | |
| 4 | 2017 | 30 | |
| 5 | 2020 | 20 | |
| 6 | 2020 | 19 | |
| 7 | 2022 | 19 | |
| 8 | 2021 | 16 | |
| 9 | 2016 | 14 | |
| 10 | 2020 | 14 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 12 | |
| 13 | 2020 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2011 | 8 | |
| 18 | 2020 | 7 | |
| 19 | 2019 | 4 | |
| 20 | 2024 | 4 |
About Alan Leeb
Alan Leeb is a scholar working on Toxicology, Epidemiology, Infectious Diseases, Immunology and Allergy and Health, having authored 30 papers that have together received 356 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (18 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Influenza Virus Research Studies (3 papers), Herpesvirus Infections and Treatments (3 papers), Vaccine Coverage and Hesitancy (2 papers), Mobile Health and mHealth Applications (2 papers), Food Allergy and Anaphylaxis Research (2 papers) and Cervical Cancer and HPV Research (1 paper). The work is most often cited by research in Toxicology (179 citations), Health (37 citations), Epidemiology (97 citations), Immunology and Allergy (14 citations) and Infectious Diseases (50 citations). Alan Leeb has collaborated with scholars based in Australia, United Kingdom and Qatar. Frequent co-authors include Kristine K. Macartney, Patrick M. Cashman, Alexis Pillsbury, Helen Quinn, Annette K. Regan, Tom Snelling, Catherine Glover, Christopher C. Blyth, Parveen Fathima and Paul V. Effler. Their work appears in journals such as Vaccine, BMJ Open, The Medical Journal of Australia, Human Vaccines & Immunotherapeutics and The Lancet Regional Health - Western Pacific.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.